Comparative Effectiveness of Commercial Bowel Preparations in Ambulatory Patients Presenting for Screening or Surveillance Colonoscopy.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
06 2021
Historique:
received: 26 04 2020
accepted: 11 07 2020
pubmed: 22 7 2020
medline: 2 9 2021
entrez: 22 7 2020
Statut: ppublish

Résumé

Inadequate bowel preparation (IBP) is associated with reduced adenoma detection. However, limited research has examined the impact of different commercial bowel preparations (CBPs) on IBP and adenoma detection. We aim to determine whether type of CBP used is associated with IBP or adenoma detection. We retrospectively evaluated outpatient, screening or surveillance colonoscopies performed in the Cleveland Clinic health system between January 2011 and June 2017. IBP was defined by the Aronchick scale. Multilevel mixed-effects logistic regression was performed to assess the association between CBP type and IBP and adenoma detection. Fixed effects were defined as demographics, comorbidities, medication use, and colonoscopy factors. Random effect of individual endoscopist was considered. Of 153,639 colonoscopies, 75,874 records met inclusion criteria. Median age was 54; 50% were female; 17.7% had IBP, and adenoma detection rate was 32.6%. In adjusted analyses, compared to GoLYTELY, only NuLYTELY [OR 0.66 (95% CI 0.60, 0.72)] and SuPREP [OR 0.53 (95% CI 0.40, 0.69)] were associated with reduced IBP. Adenoma detection did not vary based on the type of bowel preparation used. Among patients referred for screening or surveillance colonoscopy, choice of CBP was not associated with adenoma detection. Decisions about CBP should be based on other factors, such as tolerability, cost, or safety.

Sections du résumé

BACKGROUND
Inadequate bowel preparation (IBP) is associated with reduced adenoma detection. However, limited research has examined the impact of different commercial bowel preparations (CBPs) on IBP and adenoma detection. We aim to determine whether type of CBP used is associated with IBP or adenoma detection.
METHODS
We retrospectively evaluated outpatient, screening or surveillance colonoscopies performed in the Cleveland Clinic health system between January 2011 and June 2017. IBP was defined by the Aronchick scale. Multilevel mixed-effects logistic regression was performed to assess the association between CBP type and IBP and adenoma detection. Fixed effects were defined as demographics, comorbidities, medication use, and colonoscopy factors. Random effect of individual endoscopist was considered.
RESULTS
Of 153,639 colonoscopies, 75,874 records met inclusion criteria. Median age was 54; 50% were female; 17.7% had IBP, and adenoma detection rate was 32.6%. In adjusted analyses, compared to GoLYTELY, only NuLYTELY [OR 0.66 (95% CI 0.60, 0.72)] and SuPREP [OR 0.53 (95% CI 0.40, 0.69)] were associated with reduced IBP. Adenoma detection did not vary based on the type of bowel preparation used.
CONCLUSIONS
Among patients referred for screening or surveillance colonoscopy, choice of CBP was not associated with adenoma detection. Decisions about CBP should be based on other factors, such as tolerability, cost, or safety.

Identifiants

pubmed: 32691384
doi: 10.1007/s10620-020-06492-z
pii: 10.1007/s10620-020-06492-z
pmc: PMC8794767
mid: NIHMS1769240
doi:

Substances chimiques

Cathartics 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2059-2068

Subventions

Organisme : NIDDK NIH HHS
ID : T32 DK083266
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Becker EA, Buscemi J, Fitzgibbon ML, et al. Society of Behavioral Medicine (SBM) position statement: SBM supports the National Colorectal Cancer Roundtable’s (NCCRT) call to action to reach 80% colorectal cancer screening rates by 2018. Transl Behav Med. 2016;6:306–308.
doi: 10.1007/s13142-015-0364-6
Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121:2281–2285.
doi: 10.1002/cncr.29336
Chokshi RV, Hovis CE, Hollander T, Early DS, Wang JS. Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc. 2012;75:1197–1203.
doi: 10.1016/j.gie.2012.01.005
Cheng RW, Chiu YC, Wu KL, et al. Predictive factors for inadequate colon preparation before colonoscopy. Tech Coloproctol. 2015;19:111–115.
doi: 10.1007/s10151-014-1259-0
Hassan C, Fuccio L, Bruno M, et al. A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2012;10:501–506.
Van Dongen M. Enhancing bowel preparation for colonoscopy: an integrative review. Gastroenterol Nurs. 2012;35:36–44.
doi: 10.1097/SGA.0b013e3182403413
Jawa H, Mosli M, Alsamadani W, et al. Predictors of inadequate bowel preparation for inpatient colonoscopy. Turk J Gastroenterol. 2017;28:460–464.
doi: 10.5152/tjg.2017.17196
Gandhi K, Tofani C, Sokach C, Patel D, Kastenberg D, Daskalakis C. Patient characteristics associated with quality of colonoscopy preparation: a systematic review and meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2018;16:357–369.
Rex DK. Optimal bowel preparation–a practical guide for clinicians. Nat Rev Gastroenterol Hepatol. 2014;11:419–425.
doi: 10.1038/nrgastro.2014.35
Chaptini L, Laine L. Can I improve my adenoma detection rate? J Clin Gastroenterol. 2015;49:270–281.
doi: 10.1097/MCG.0000000000000293
Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London, England). 2014;383:1490–1502.
doi: 10.1016/S0140-6736(13)61649-9
Kumar K, Mohindra S, Raj M, Choudhuri G. Procalcitonin as a marker of sepsis in alcoholic hepatitis. Hepatol Int. 2014;8:436–442.
doi: 10.1007/s12072-014-9540-x
Bardou M, Barkun A, Martel M. Effect of statin therapy on colorectal cancer. Gut. 2010;59:1572–1585.
doi: 10.1136/gut.2009.190900
Sehdev A, O’Neil BH. The role of aspirin, vitamin d, exercise, diet, statins, and metformin in the prevention and treatment of colorectal cancer. Curr Treat Options Oncol. 2015;16:43.
doi: 10.1007/s11864-015-0359-z
Aronchick CA, Lipshutz WH, Wright SH, Dufrayne F, Bergman G. A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointest Endosc. 2000;52:346–352.
doi: 10.1067/mge.2000.108480
Martin D, Walayat S, Ahmed Z, et al. Impact of bowel preparation type on the quality of colonoscopy: a multicenter community-based study. J Commun Hosp Intern Med Perspect. 2016;6:31074.
doi: 10.3402/jchimp.v6.31074
Gu P, Lew D, Oh SJ, et al. Comparing the real-world effectiveness of competing colonoscopy preparations: results of a prospective trial. Am J Gastroenterol. 2019;114:305–314.
doi: 10.14309/ajg.0000000000000057
DiPalma JA, Marshall JB. Comparison of a new sulfate-free polyethylene glycol electrolyte lavage solution versus a standard solution for colonoscopy cleansing. Gastrointest Endosc. 1990;36:285–289.
doi: 10.1016/S0016-5107(90)71025-5
Ko CW, Dominitz JA, Green P, Kreuter W, Baldwin LM. Specialty differences in polyp detection, removal, and biopsy during colonoscopy. Am J Med. 2010;123:528–535.
doi: 10.1016/j.amjmed.2010.01.016
Good Rx. Stop paying too much for your prescriptions. 2019
Woo DH, Kim KO, Jeong DE, et al. Prospective analysis of factors associated with inadequate bowel preparation for colonoscopy in actual clinical practice. Intest Res. 2018;16:293–298.
doi: 10.5217/ir.2018.16.2.293
Siddiki H, Ravi S, Al-Qaisi MT, et al. Comparison of small versus large volume split dose preparation for colonoscopy: a study of colonoscopy outcomes. Dig Dis Sci. 2018;63:2413–2418. https://doi.org/10.1007/s10620-018-5102-8 .
doi: 10.1007/s10620-018-5102-8 pubmed: 29736830 pmcid: 29736830
Perreault G, Goodman A, Larion S, et al. Split-versus single-dose preparation tolerability in a multiethnic population: decreased side effects but greater social barriers. Ann Gastroenterol. 2018;31:356–364.
pubmed: 29720862 pmcid: 29720862
Horton N, Garber A, Hasson H, Lopez R, Burke CA. Impact of single- vs. split-dose low-volume bowel preparations on bowel movement kinetics, patient inconvenience, and polyp detection: a prospective trial. Am J Gastroenterol.. 2016;111:1330–1337.
doi: 10.1038/ajg.2016.273
Kang X, Zhao L, Zhu Z, et al. Same-day single dose of 2 liter polyethylene glycol is not inferior to the standard bowel preparation regimen in low-risk patients: a randomized, controlled trial. Am J Gastroenterol. 2018;113:601–610.
doi: 10.1038/ajg.2018.25
Sanaka MR, Shah N, Mullen KD, Ferguson DR, Thomas C, McCullough AJ. Afternoon colonoscopies have higher failure rates than morning colonoscopies. Am J Gastroenterol. 2006;101:2726–2730.
doi: 10.1111/j.1572-0241.2006.00887.x
Wells CD, Heigh RI, Sharma VK, et al. Comparison of morning versus afternoon cecal intubation rates. BMC Gastroenterol. 2007;7:19.
doi: 10.1186/1471-230X-7-19
Gupta T, Mandot A, Desai D, Abraham P, Joshi A, Shah S. Comparison of two schedules (previous evening versus same morning) of bowel preparation for colonoscopy. Endoscopy. 2007;39:706–709.
doi: 10.1055/s-2007-966375
Eun CS, Han DS, Hyun YS, et al. The timing of bowel preparation is more important than the timing of colonoscopy in determining the quality of bowel cleansing. Dig Dis Sci. 2011;56:539–544. https://doi.org/10.1007/s10620-010-1457-1 .
doi: 10.1007/s10620-010-1457-1 pubmed: 21042853 pmcid: 21042853
Singh S, Dhawan M, Chowdhry M, Babich M, Aoun E. Differences between morning and afternoon colonoscopies for adenoma detection in female and male patients. Ann Gastroenterol. 2016;29:497–501.
pubmed: 27708517 pmcid: 27708517
Quan H, Li B, Saunders LD, et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43:1424–1441.
doi: 10.1111/j.1475-6773.2007.00822.x
Hsueh FC, Wang HC, Sun CA, et al. The effect of different patient education methods on quality of bowel cleanliness in outpatients receiving colonoscopy examination. Appl Nurs Res. 2014;27:e1–e5.
doi: 10.1016/j.apnr.2013.12.004
Prakash SR, Verma S, McGowan J, et al. Improving the quality of colonoscopy bowel preparation using an educational video. Can J Gastroenterol. 2013;27:696–700.
doi: 10.1155/2013/292636
Parmar R, Martel M, Rostom A, Barkun AN. Validated scales for colon cleansing: a systematic review. Am J Gastroenterol. 2016;111:197–204. (quiz 205).
doi: 10.1038/ajg.2015.417
Kastenberg D, Bertiger G, Brogadir S. Bowel preparation quality scales for colonoscopy. World J Gastroenterol. 2018;24:2833–2843.
doi: 10.3748/wjg.v24.i26.2833

Auteurs

Shashank Sarvepalli (S)

Department of Gastroenterology and Hepatology, Baylor College of Medicine, 7200 Cambridge St, Suite 8B, Houston, TX, 77030, USA. shashank.sarvepalli@gmail.com.

Ari Garber (A)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.

Carol A Burke (CA)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.

Niyati Gupta (N)

Department of Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Mounir Ibrahim (M)

Department of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA.

John McMichael (J)

Department of General Surgery, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.

Gareth Morris-Stiff (G)

Department of General Surgery, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.

Amit Bhatt (A)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.

John Vargo (J)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.

Maged Rizk (M)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.

Michael B Rothberg (MB)

Department of Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Center for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH